drugset / Trial / NCT05774184
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2025-06-04
- Completion
- 2026-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | barzolvolimab | Monoclonal antibody | 300 mg | Subcutaneous |